View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Korro Presents Additional Preclinical Data for KRRO-110 at the America...

Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week 13 in an in vivo genetic Alpha-1 Antitrypsin Deficiency (AATD) mouse modelKRRO-110 showed 35µM of M-AAT one week post the first dose, with 0µM of M-AAT at baseline, increasing to 45µM of M-AAT at week 13 CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) --  Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical com...

 PRESS RELEASE

$146.5 Million Inland Empire Multifamily Sale Closed By Marcus & Milli...

MURRIETA, Calif.--(BUSINESS WIRE)-- , a division of , announced the sale of Silverado Apartment Homes, a 492-unit multifamily property in Murrieta, California. The property sold for $146.5 million, which equates to $297,764 per unit. “Silverado presented a unique opportunity to acquire a newer vintage Inland Empire asset with substantial upside in a burgeoning submarket with strong fundamentals,” said Kevin Green, IPA executive managing director investments. “Our controlled process was met with a positive response and yielded a highly competitive sales environment. The opportunity was bolste...

 PRESS RELEASE

Axway Software : Déclaration des transactions sur actions propres

PARIS--(BUSINESS WIRE)-- Regulatory News: Dans le cadre de l’autorisation consentie par l’Assemblée Générale mixte du 16 mai 2024 pour la mise en œuvre d’un programme de rachat d’actions, Axway Software SA (Paris:AXW) (LEI : 96950022O6SP7FQONJ77) déclare ci-après les achats d’actions propres (FR0011040500) réalisés du 13 au 17 mai 2024 : Jour de latransaction Volume total journalier(nombre de titres) Prix pondérémoyen d'acquisition(€/action) Montant destransactions(€) Code identifiantmarché 13/05/2024 810 24.99 20,241 XPAR 14/05/2024 733 24.73 18,1...

Synaptics, Inc.: Update to credit analysis

Our credit view of this issuer reflects its niche market leadership positions and consistently positive FCF generation, against its small revenue scale.

Moody's Ratings assigns A3 rating to PayPal's proposed senior unsecure...

Moody's Ratings (Moody's) assigned an A3 rating to PayPal Holdings, Inc.'s (PayPal) proposed senior unsecured notes. The ratings outlook is stable. The net proceeds of the offering will be used for general corporate purposes including prefunding senior notes maturing October 1, 2024. RATINGS RATIO...

 PRESS RELEASE

Press Release: Dupixent® late-breaking data from NOTUS confirmatory ph...

Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM   Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammationData support the potential of Dupixent as the first new treatment approach in mo...

 PRESS RELEASE

Communiqué de presse : Présentation à l’ATS et publication dans le NEJ...

Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCO Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCO Les résultats de l’étude NOTUS confirment les données décisives de l’étude de phase III BOREAS et montrent que, dans le traitement de la bronchopneumopathie chronique obstructive (BPCO) avec signature inflammatoire de ty...

 PRESS RELEASE

Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase...

Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine NOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammation Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD TARRYTOWN, N.Y. and PARIS...

Xianhe Co Ltd: 1 director

A director at Xianhe Co Ltd maiden bought 1,110,000 shares at 19.853CNY and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

HP Unlocks New Era of AI Experiences Powering Work and Creation

HP Unlocks New Era of AI Experiences Powering Work and Creation World’s most powerful and secure ultra-mobile AI PCs drive next generation of AI computing with record-breaking 26 hours of battery life 1, 2, 3 News Highlights: World’s most powerful ultra-mobile next-gen AI PCs1 reclaim time for meaningful work and creationUnleash your full potential from anywhere with the world’s longest battery life in an ultra-mobile next-gen AI PC3Sleek new HP next-gen AI PCs deliver lightning-fast responsiveness with a dedicated NPU4 capable of 45 trillion operations per second (TOPS)Discover new AI su...

Moody's Ratings assigns Ba3 rating to PennyMac Financial Services, Inc...

Moody's Ratings (Moody's) has assigned a Ba3 rating to PennyMac Financial Services, Inc.'s (PFSI) proposed $650 million backed long-term senior unsecured notes maturing 2030. The notes will be guaranteed on an unsecured basis by each of PFSI's existing and future domestic subsidiaries, including Pri...

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Oscar Rönnkvist
  • Simon Jönsson

Nu Holdings Ltd: Update following rating affirmation, outlook changed ...

Our credit view of Nubank, reflecting its robust capitalization, ample access to low-cost core deposits and adequate asset quality, constrained by its modest profitability.

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Daniel Thorsson
  • Nikola Kalanoski

Contract win momentum maintained

Minor estimate changes. Solid pace of public procurement wins. '24e EV/EBITA ~9x.

Moody's Ratings affirms A1/VMIG 1 of The Health, Educational and Housi...

Moody's Ratings ("Moody's") has affirmed A1/VMIG 1 rating assigned to The Health, Educational and Housing Facility Board of the County of Shelby, Tennessee Variable Rate Revenue Bonds, Series 2008A (Methodist Le Bonheur Healthcare) ("Series 2008A") and Variable Rate Revenue Bonds, Series 2008B (Meth...

Moody's Ratings upgrades Adams & Hancock Counties CUSD 4 (Mendon), IL ...

Moody's Ratings (Moody's) has upgraded Adams & Hancock Counties Community Unit School District 4 (Mendon), IL's issuer and general obligation unlimited tax (GOULT) ratings to A1 from A2. The district had roughly six million in debt outstanding as of June 30, 2023. The upgrade to A1 is driven by gr...

Suzhou TZTEK Technology Co Ltd: 1 director

A director at Suzhou TZTEK Technology Co Ltd sold 34,000 shares at 34.090CNY and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Saudi Awwal Bank and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 14 May 2024 in which Moody's reassessed the appropriateness of the ratings in the context ...

Moody's Ratings assigns Aa1 to MWRA's Gen. Rev. Bonds 2024 Ser. B (Gre...

Moody's Ratings (Moody's) has assigned Aa1 ratings to the Massachusetts Water Resources Authority, MA's (MWRA) proposed $200 million General Revenue Bonds, 2024 Series B (Green Bonds) and $300 million General Revenue Refunding Bonds, 2024 Series C (Green Bonds). Moody's maintains the Aa1 rating on t...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch